Correspondence

Advisory Council on the Misuse of drugs: Advice on O-desmethyltramadol (2012)

The ACMD have considered the harms associated with the use of O-desmethyltramadol and recommend that O-desmethyltramadol is controlled.

From:
Advisory Council on the Misuse of Drugs
Published
23 October 2012

Documents

PDF, 77.6 KB, 2 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

O-desmethyltramadol is being offered for sale as a 鈥榣egal high鈥� and has been identified as an undeclared ingredient of a 鈥榣egal high鈥� product called 鈥楰rypton鈥�.聽

The ACMD have considered the harms associated with the use of O-desmethyltramadol and this correspondence recommends that O-desmethyltramadol is controlled under the Misuse of Drugs Act 1971.

Updates to this page

Published 23 October 2012

Sign up for emails or print this page

Related content